References
- Steegers EA, von Dadelszen P, Duvekot JJ, et al. Pre-eclampsia. Lancet. 2010;376(9741):631–644.
- Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol. 2002;101(1):6–14.
- Bartsch E, Medcalf KE, Park AL, et al. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and Meta-analysis of large cohort studies. BMJ. 2016;353:i1753.
- Conde-Agudelo A, Belizán JM. Risk factors for pre-eclampsia in a large cohort of Latin American and Caribbean women. BJOG . 2000;107(1):75–83.
- Ostlund I, Haglund B, Hanson U. Gestational diabetes and preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2004;113(1):12–16.
- Sibai BM, Hauth J, Caritis S, et al. Hypertensive disorders in twin versus singleton gestations. National institute of child health and human development network of Maternal-Fetal medicine units. Am J Obstet Gynecol. 2000;182(4):938–942.
- Smyth A, Oliveira GH, Lahr BD, et al. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol. 2010;5(11):2060–2068.
- Zhang JJ, Ma XX, Hao L, et al. A systematic review and meta-analysis of outcomes of pregnancy in CKD and CKD outcomes in pregnancy. CJASN. 2015;10(11):1964–1978.
- Wallis AB, Saftlas AF, Hsia J, et al. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987–2004. Am J Hypertens. 2008;21(5):521–526.
- Blondel B, Kaminski M. Trends in the occurrence, determinants, and consequences of multiple births. Semin Perinatol. 2002;26(4):239–249.
- Martin JA, Hamilton BE, Ventura SJ, et al. Births: final data for 2009. National vital statistics reports: from the centers for disease control and prevention. Natl Vital Stat Rep. 2011;60(1):1–70.
- Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222. Obstet Gynecol. 2020;135(6):e237–e260.
- Practice bulletin no. 169 summary: multifetal gestations: twin, triplet, and higher-order multifetal pregnancies. Obstet Gynecol. 2016;128(4):e131–e146.
- Henry DE, McElrath TF, Smith NA. Preterm severe preeclampsia in singleton and twin pregnancies. J Perinatol. 2013;33(2):94–97.
- Martins JG, Biggio JR, Abuhamad A. Society for maternal-fetal medicine consult series #52: diagnosis and management of fetal growth restriction: (replaces clinical guideline number 3, April 2012). Am J Obstet Gynecol. 2020;223(4):B2–B17.
- Bonellie SR, Currie D, Chalmers J. Comparison of risk factors for cerebral palsy in twins and singletons. Dev Med Child Neurol. 2005;47(9):587–591.
- Broekhuijsen K, van Baaren GJ, van Pampus MG, et al. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial. Lancet. 2015;385(9986):2492–2501.
- Flenady V, Koopmans L, Middleton P, et al. Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet. 2011;377(9774):1331–1340.
- Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 2012;36(1):56–59.
- Gilbert WM, Danielsen B. Pregnancy outcomes associated with intrauterine growth restriction. Am J Obstet Gynecol. 2003;188(6):1596; discussion 1599–1601.
- Hehir MP, Breathnach FM, McAuliffe FM, et al. Gestational hypertensive disease in twin pregnancy: Influence on outcomes in a large national prospective cohort. Aust N Z J Obstet Gynaecol. 2016;56(5):466–470.
- James AH, Bushnell CD, Jamison MG, et al. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol. 2005;106(3):509–516.
- McPherson JA, Odibo AO, Shanks AL, et al. Impact of chorionicity on risk and timing of intrauterine fetal demise in twin pregnancies. Am J Obstet Gynecol. 2012;207(3):190.e1–190.e6.
- Page JM, Pilliod RA, Snowden JM, et al. The risk of stillbirth and infant death by each additional week of expectant management in twin pregnancies. Am J Obstet Gynecol. 2015;212(5):630.e1–630.e7.
- Secher NJ, Kaern J, Hansen PK. Intrauterine growth in twin pregnancies: prediction of fetal growth retardation. Obstet Gynecol. 1985;66(1):63–68.
- Xiong X, Mayes D, Demianczuk N, et al. Impact of pregnancy-induced hypertension on fetal growth. Am J Obstet Gynecol. 1999;180(1):207–213.
- Yıldırım G, Güngördük K, Aslan H, et al. Comparison of perinatal and maternal outcomes of severe preeclampsia, eclampsia, and HELLP syndrome. J Turk Ger Gynecol Assoc. 2011;12(2):90–96.
- Yuan T, Wang W, Li XL, et al. Clinical characteristics of fetal and neonatal outcomes in twin pregnancy with preeclampsia in a retrospective case-control study: a STROBE-compliant article. Medicine. 2016;95(43):e5199.
- Zhang J, Meikle S, Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy. 2003;22(2):203–212.
- Carroll AE, Downs SM. Comprehensive cost-utility analysis of newborn screening strategies. Pediatrics. 2006;117(5 Pt 2):S287–S295.
- Grobman WA, Dooley SL, Welshman EE, et al. Preference assessment of prenatal diagnosis for down syndrome: is 35 years a rational cutoff? Prenat Diagn. 2002;22(13):1195–1200.
- Kuppermann M, Nease RF, Learman LA, et al. Procedure-related miscarriages and down syndrome-affected births: implications for prenatal testing based on women's preferences. Obstet Gynecol. 2000;96(4):511–516.
- Post PN, Stiggelbout AM, Wakker PP. The utility of health states after stroke: a systematic review of the literature. Stroke. 2001;32(6):1425–1429.
- National Center for Health S. Health, United States. Health, United States, 2011. With special feature on socioeconomic status and health. Hyattsville (MD): National Center for Health Statistics (US); 2012.
- Russell LB, Gold MR, Siegel JE, et al. The role of cost-effectiveness analysis in health and medicine. Panel on cost-effectiveness in health and medicine. JAMA. 1996;276(14):1172–1177.
- Powers WF, Kiely JL. The risks confronting twins: a national perspective. Am J Obstet Gynecol. 1994;170(2):456–461.
- Ounsted M, Moar VA, Scott A. Risk factors associated with small-for-dates and large-for-dates infants. Br J Obstet Gynaecol. 1985;92(3):226–232.
- Koopmans CM, Bijlenga D, Groen H, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009;374(9694):979–988.
- Chappell LC, Brocklehurst P, Green ME, et al. Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial. Lancet. 2019;394(10204):1181–1190.
- Sibai BM. Management of late preterm and early-term pregnancies complicated by mild gestational hypertension/pre-eclampsia. Semin Perinatol. 2011;35(5):292–296.
- Surman GH, King A, Gallagher M, et al. 4Child: four countries database of cerebral palsy, vision loss and hearing loss in children. In: Annual report 2009, including data for births 1984 to 2003. Oxford: University of Oxford; 2009.